UMN Pharma Inc.
株式会社ＵＭＮファーマ
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4585
FY2018 · 2018-12-31
| Gross margin | 98.4% |
| Operating margin | -585.6% |
| Net margin | -703.3% |
| Return on equity | — |
| Return on assets | -61.9% |
| Revenue growth (YoY) | -0.4% |
| EPS (basic) | ¥-55.12 |
| EPS growth (YoY) | — |
| Current ratio | 20.38x |
| Equity ratio | 31.7% |
| Book value / share | ¥24.43 |
| Free cash flow | -740 M |